Dashboard
Manage Tickers

ARCT Arcturus Therapeutics Holdi...

Nasdaq arcturusrx.com


$ 5.89 $ -0.31 (-4.98 %)    

Thursday, 20-Nov-2025 13:52:45 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 588.67 $ -22.93 (-3.75 %)
DIA $ 458.09 $ -8.59 (-1.84 %)
SPY $ 654.51 $ -18.39 (-2.73 %)
TLT $ 89.26 $ 0.27 (0.3 %)
GLD $ 373.13 $ -2.05 (-0.55 %)
$ 6.04
$ 6.29
$ 5.87 x 600
$ 5.91 x 548
$ 5.87 - $ 6.38
$ 6.02 - $ 24.17
1,036,111
na
171.61M
$ 2.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-12-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
3 05-12-2025 03-31-2025 10-Q
4 03-06-2025 01-01-1970 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-05-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 03-14-2024 12-31-2023 10-K
9 11-14-2023 09-30-2023 10-Q
10 08-07-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-29-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-09-2022 03-31-2022 10-Q
16 03-01-2022 12-31-2021 10-K
17 11-09-2021 09-30-2021 10-Q
18 08-10-2021 06-30-2021 10-Q
19 05-10-2021 03-31-2021 10-Q
20 03-01-2021 12-31-2020 10-K
21 11-09-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-08-2020 03-31-2020 10-Q
24 03-16-2020 12-31-2019 10-K
25 11-08-2019 09-30-2019 10-Q
26 08-14-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

citigroup-maintains-neutral-on-arcturus-therapeutics-lowers-price-target-to-9
Citigroup Maintains Neutral on Arcturus Th...
11/13/2025 20:05:54

Citigroup analyst Yigal Nochomovitz maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Neutral and lowers the price target...

piper-sandler-maintains-overweight-on-arcturus-therapeutics-lowers-price-target-to-72
Piper Sandler Maintains Overweight on Arct...
11/11/2025 17:19:24

Piper Sandler analyst Yasmeen Rahimi maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Overweight and lowers the price ta...

hc-wainwright--co-maintains-neutral-on-arcturus-therapeutics-lowers-price-target-to-9
HC Wainwright & Co. Maintains Neutral on A...
11/11/2025 16:27:28

HC Wainwright & Co. analyst Andrew S. Fein maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Neutral and lowers the p...

arcturus-therapeutics-q3-eps-049-beats-090-estimate-sales-17151m-miss-21196m-estimate
Arcturus Therapeutics Q3 EPS $(0.49) Beats...
11/10/2025 21:01:46

Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of...

earnings-scheduled-for-november-10-2025
Earnings Scheduled For November 10, 2025
11/10/2025 11:12:02

preview-arcturus-therapeuticss-earnings
Preview: Arcturus Therapeutics's Earnings
11/07/2025 18:05:56

this-molina-healthcare-analyst-turns-bearish-here-are-top-5-downgrades-for-friday
This Molina Healthcare Analyst Turns Beari...
10/24/2025 11:57:02

hc-wainwright--co-downgrades-arcturus-therapeutics-to-neutral-lowers-price-target-to-12
HC Wainwright & Co. Downgrades Arcturus Th...
10/24/2025 10:44:02

HC Wainwright & Co. analyst Andrew S. Fein downgrades Arcturus Therapeutics (NASDAQ:ARCT) from Buy to Neutral and lowers...

citigroup-downgrades-arcturus-therapeutics-to-neutral-lowers-price-target-to-12
Citigroup Downgrades Arcturus Therapeutics...
10/23/2025 16:54:47

Citigroup analyst Yigal Nochomovitz downgrades Arcturus Therapeutics (NASDAQ:ARCT) from Buy to Neutral and lowers the price ...

where-arcturus-therapeutics-stands-with-analysts
Where Arcturus Therapeutics Stands With An...
10/22/2025 21:01:26

arcturus-investigational-inhaled-therapy-lacks-meaningful-lung-function-improvement-analyst-notes-mixed-picture
Arcturus' Investigational Inhaled Therapy ...
10/22/2025 19:05:36

Arcturus stock drops on interim Phase 2 results for ARCT-032, showing promising mucus reduction in cystic fibrosis patients but...

btig-maintains-buy-on-arcturus-therapeutics-lowers-price-target-to-23
BTIG Maintains Buy on Arcturus Therapeutic...
10/22/2025 17:42:07

BTIG analyst Thomas Shrader maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and lowers the price target from $48 to...

crude-oil-gains-over-1-att-shares-slide-after-q3-results
Crude Oil Gains Over 1%; AT&T Shares Slide...
10/22/2025 17:13:45

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/22/2025 17:06:27

guggenheim-downgrades-arcturus-therapeutics-to-neutral
Guggenheim Downgrades Arcturus Therapeutic...
10/22/2025 15:29:35

Guggenheim analyst Seamus Fernandez downgrades Arcturus Therapeutics (NASDAQ:ARCT) from Buy to Neutral.

dow-falls-100-points-netflix-shares-tumble-on-downbeat-earnings
Dow Falls 100 Points; Netflix Shares Tumbl...
10/22/2025 14:12:32

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/22/2025 12:09:33

arcturus-announces-interim-results-from-ongoing-phase-2-clinical-trial-of-arct-032-investigational-inhaled-mrna-therapy-for-people-with-cystic-fibrosis
Arcturus Announces Interim Results From On...
10/22/2025 11:34:38

ARCT-032 generally safe and well toleratedMeaningful trends of clinical activity observed via high resolution CT scansAfter onl...

Core News & Articles
10 Health Care Stocks With Whale Alerts In...
09/29/2025 17:35:29

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and...

cathie-woods-ark-bets-big-on-solana-treasury-play-makes-162m-investment-in-brera-holdings-as-stock-explodes-225
Cathie Wood's Ark Bets Big On Solana Treas...
09/19/2025 01:42:06

On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and b...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION